Associations with anticoagulation: A cross-sectional registry-based analysis of stroke survivors with atrial fibrillation

Heart

Volumn 100, Issue 7, 2014, Pages 557-562

  Abdul Rahim, Azmil H ^a   Wong, Jao ^a   McAlpine, Christine ^b   Young, Camilla ^b   Quinn, Terence J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K;

AGED; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SOCIOECONOMICS; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; REGISTRIES; STROKE; SURVIVORS;

EID: 84896544333     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305267     Document Type: Article

References (28)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25. (Pubitemid 44420743)
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67. (Pubitemid 351650486)
4. Camm AJ, Kirchhof P, Lip GYH, et al.; European Heart Rhythm Association, European Association for Cardio-Thoracic Society. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
5. National Collaborating Centre for Chronic Conditions (UK). Atrial Fibrillation: National clinical guideline for management in primary and secondary care. London: Royal College of Physicians of London, 2006.
6. Scottish Intercollegiate Guidelines Network. Management of patients with stroke and TIA: assessment, investigation, immediate management and secondary prevention. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland, 2008.
7. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70. (Pubitemid 32537350)
8. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137:263-72.
9. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100.
10. Chronic Disease in the NHS Greater Glasgow & Clyde. Insights from Local Enhanced Services 2008-2009. Glasgow: NHS Greater Glasgow & Clyde, 2010. http://www.nhsggc.org.uk/content/default.asp?page=s1432-2 (accessed 1 May 2013).
11. Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131:927-34. (Pubitemid 30005032)
12. Nieuwlaat R, Capucci A, Lip GY, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006;27:3018-26. (Pubitemid 44963431)
13. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9. (Pubitemid 351289042)
14. Fitzmaurice DA, Hobbs FD, Jowett S, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007;335:383.
15. Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation 2004;110:368-73. (Pubitemid 38993844)
16. Scottish Index of Multiple Deprivation (SIMD). Edinburgh: The Scottish Government, 2013. http://www.scotland.gov.uk/Topics/Statistics/SIMD (accessed 1 May 2013).
17. Gordi T, Khamis H. Simple solution to a common statistical problem: interpreting multiple tests. Clin Ther 2004;26:780-6. (Pubitemid 38736968)
18. Scowcroft AC, Lee S, Mant J. Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009. Heart 2013;99:127-32.
19. Ruigomez A, Johansson S, Wallander MA, et al. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002;55:358-63. (Pubitemid 34245363)
20. Watt G. The inverse care law today. Lancet 2002;360:252-4. (Pubitemid 34804658)
21. Kerr GD, Slavin H, Clark D, et al. Do vascular risk factors explain the association between socioeconomic status and stroke incidence: a meta-analysis. Cerebrovasc Dis 2011;31:57-63.
22. Cox AM, McKevitt C, Rudd AG, et al. Socioeconomic status and stroke. Lancet Neurol 2006;5:181-8. (Pubitemid 43107853)
23. Rash A, Downes T, Portner R, et al. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 2007;36:151-6. (Pubitemid 46455393)
24. Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
25. Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009;40:235-40.
26. Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? JTH 2008;6:1500-6.
27. Glader EL, Sjolander M, Eriksson M, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010;41:397-401.
28. Abdul-Rahim AH, Lees KR. Paroxysmal atrial fibrillation after ischemic stroke: how should we hunt for it? Expert Rev Cardiovasc Ther 2013;11:485-94.